Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Personalis, Inc. United States | 1 | 413 |
|
Tempus AI - RTP United States | 2 | 647 |
|
SMC3 Gene Cornelia de Lange syndrome type 3 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Foundation Medicine, Inc. United States | 2 | 405 |
|
Myeloid Next Generation Sequencing with Reflex Pathology Interp Sentara Healthcare Laboratory Services United States | 3 | 69 |
|
UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 1 | 52 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
UCSF Molecular Diagnostics Laboratory UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 4 | 52 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
SMC3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
MayoComplete Solid Tumor Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 476 |
|
Invitae Neurodevelopmental Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 404 | 241 |
|
The Jackson Laboratory for Genomic Medicine United States | 1 | 517 |
|
Myeloid NextGen Sequencing Assay with Calreticulin Exon 9 Mutation PathGroup United States | 16 | 65 |
|
Myeloid NextGen Sequencing Assay PathGroup United States | 16 | 65 |
|
Myeloid NextGen Sequencing Assay with FLT3 ITD and TKD Analysis PathGroup United States | 16 | 65 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.